Brokerages Set Ardent Health Partners, LLC (NYSE:ARDT) Target Price at $21.82

Shares of Ardent Health Partners, LLC (NYSE:ARDT) have received a consensus rating of “Buy” from the twelve ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $22.00.

ARDT has been the subject of several recent analyst reports. JPMorgan Chase & Co. restated a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Leerink Partners raised their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th. Stephens restated an “overweight” rating and set a $24.00 target price on shares of Ardent Health Partners in a research note on Thursday, September 19th. Bank of America cut Ardent Health Partners from a “buy” rating to a “neutral” rating and decreased their price target for the company from $22.00 to $19.00 in a research note on Wednesday, November 6th. Finally, KeyCorp began coverage on Ardent Health Partners in a research note on Friday, October 11th. They set an “overweight” rating and a $24.00 price target on the stock.

Institutional Trading of Ardent Health Partners

Several institutional investors and hedge funds have recently bought and sold shares of ARDT. Wellington Management Group LLP purchased a new position in shares of Ardent Health Partners during the third quarter worth $28,724,000. Point72 Asset Management L.P. acquired a new stake in Ardent Health Partners during the 3rd quarter worth about $27,428,000. Goldentree Asset Management LP acquired a new stake in Ardent Health Partners during the 3rd quarter worth about $22,897,000. Franklin Resources Inc. purchased a new position in shares of Ardent Health Partners during the 3rd quarter valued at about $15,839,000. Finally, Allspring Global Investments Holdings LLC purchased a new stake in shares of Ardent Health Partners in the third quarter worth about $13,119,000.

Ardent Health Partners Stock Performance

NYSE:ARDT opened at $16.01 on Friday. The firm has a 50-day moving average price of $17.24. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. Ardent Health Partners has a fifty-two week low of $14.57 and a fifty-two week high of $20.72.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.